Initial results from the the STAMPEDE trial suggest that Docetaxol can improve survival of hormone naive advanced prostate cancer patients by 10 months. This may change the standard of care.
Menu
≡
╳
- Consultations
- Consultants
- Conditions
- GP resources
-
Treatments
- Bladder Cancer
- Hydrogel Spacer for Prostate Cancer Patients undergoing Radical Radiotherapy
- Incontinence
- Kidney Stones
- Laser Prostatectomy/TURP
- Laparoscopic Adrenalectomy
- Laparoscopic Nephrectomy
- Laparoscopic Pyeloplasty (PUJ Obstruction)
- ‘Local Anaesthetic’ Bladder Botox Injections
- Male Circumcision
- Percutaneous Tibial Nerve Stimulation (PTNS) for overactive bladder
- Robot assisted Laparoscopic Cystectomy (RALC)
- Robot assisted Laparoscopic Partial Nephrectomy
- Robot Assisted Laparoscopic Prostatectomy (RALP)
- Scrotal Surgery
- Urolift
- CONTACT US